Literature DB >> 2587127

Biotinidase deficiency: a cause of subacute necrotizing encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome.

E R Baumgartner1, T M Suormala, H Wick, A Probst, U Blauenstein, C Bachmann, M Vest.   

Abstract

An unusual clinical course of a patient with biotinidase deficiency, causing Leigh syndrome, is reported. Laryngeal stridor was the major presenting symptom followed by progressive neurologic deterioration and death at the age of 21.5 mo. Absence of skin and hair abnormalities as well as of organic aciduria delayed the correct diagnosis. Necropsy revealed subacute necrotizing encephalopathy (Leigh syndrome). Carboxylase activities (propionyl CoA carboxylase, 3-methylcrotonyl-CoA carboxylase, pyruvate carboxylase) measured in lymphocytes 1 day before death were decreased to 10% of normal values. Propionyl-CoA carboxylase was shown to be the only stable carboxylase in human postmortem tissue; in our patient it was moderately decreased in postmortem liver (29% of control) and kidney (42%), but severely decreased in brain (3%). These findings might explain the severity of neurological symptoms in the absence of marked organic aciduria. They indicate that in biotinidase deficiency the CNS may become biotin depleted earlier and more severely than other organs. Biotinidase deficiency should be included in the differential diagnosis of Leigh syndrome and of unexplained respiratory problems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587127     DOI: 10.1203/00006450-198909000-00021

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

1.  Improved neuronal tract tracing with stable biocytin-derived neuroimaging agents.

Authors:  Anurag Mishra; Kirti Dhingra; Almut Schüz; Nikos K Logothetis; Santiago Canals
Journal:  ACS Chem Neurosci       Date:  2009-10-06       Impact factor: 4.418

2.  Compulsory hyperventilation and hypocapnia of patients with Leigh syndrome associated with SURF1 gene mutations as a cause of low serum bicarbonates.

Authors:  E Pronicka; D H Piekutowska-Abramczuk; E Popowska; M Pronicki; E Karczmarewicz; Y Sykut-Cegielskâ; J Taybert
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

3.  Comparison of patients with complete and partial biotinidase deficiency: biochemical studies.

Authors:  T M Suormala; E R Baumgartner; H Wick; S Scheibenreiter; S Schweitzer
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 4.  Magnetic resonance imaging in lactic acidosis.

Authors:  M S van der Knaap; C Jakobs; J Valk
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 5.  Neuropathology and pathogenesis of mitochondrial diseases.

Authors:  G K Brown; M V Squier
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Cerebrospinal fluid organic acids in biotinidase deficiency.

Authors:  M Duran; E R Baumgartner; T M Suormala; L Bruinvis; L Dorland; J A Smeitink; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  First trimester prenatal exclusion of biotinidase deficiency.

Authors:  R A Chalmers; J Mistry; P W Docherty; D Stratton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Authors:  W Lehnert; W Sperl; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

9.  The first nuclear-encoded complex I mutation in a patient with Leigh syndrome.

Authors:  J Loeffen; J Smeitink; R Triepels; R Smeets; M Schuelke; R Sengers; F Trijbels; B Hamel; R Mullaart; L van den Heuvel
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

10.  Na(+)-dependent biotin transport into brush-border membrane vesicles from human kidney cortex.

Authors:  B Baur; E R Baumgartner
Journal:  Pflugers Arch       Date:  1993-02       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.